Vitiligo: Clinical Trials

12 trials for Vitiligo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 312Completed 12
Phase 23Completed 3

Follow Vitiligo: new trials by email Literature Review of Vitiligo trials Research Report on Vitiligo

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.
Latanoprost 0.005% Ophthalmic Solution, 5Fluorouracil - Vitiligo
Phase 2 / Phase 3CompletedSouth Valley University402022-03-152023-07-11
Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo
ruxolitinib, Vehicle - Vitiligo
Phase 3CompletedIncyte Corporation4582020-09-242025-08-14
Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)
Ruxolitinib cream, Vehicle - Non-segmental Vitiligo
Phase 3CompletedIncyte Corporation3442019-10-032025-08-22
Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)
Ruxolitinib cream, Vehicle - Non-segmental Vitiligo
Phase 3CompletedIncyte Corporation3302019-09-202025-08-22
Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC
tacrolimus, Placebo - Vitiligo
Phase 3CompletedUniversity Hospital, Bordeaux422016-02-232021-04-19
Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism
VITICELL, PLACEBO - Vitiligo, Piebaldism
Phase 3CompletedLaboratoires Genévrier382014-04-292019-10-14
Epidermal Cell Transplantation in Vitiligo Skin
Grafting with epidermal cells, UVB treatment - VITILIGO
Phase 2 / Phase 3CompletedCentre Hospitalier Universitaire de Nice232011-05-012013-05-30
Interest of the Dermabrasion by Laser Erbium in the Treatment of the Vitiligo
Group Laser = Arm A, Bras B : The group control - Vitiligo
Phase 2 / Phase 3CompletedCentre Hospitalier Universitaire de Nice202010-03-012012-03-26
Excimer Lamp Versus Excimer Laser in Vitiligo Treatment
308nm excimer lamp, 308nm excimer laser - Vitiligo
Phase 3CompletedCentre Hospitalier Universitaire de Nice2009-03-172026-06-16
Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin
Melanocyte transplantation - Vitiligo
Phase 3CompletedRoyan Institute3002009-02-012016-07-20
Vitiligo Skin Transplantation
Melanocyte-keratinocyte transplantation procedure (MKTP) - Vitiligo
Phase 3CompletedHenry Ford Health System402009-01-012012-09-06
Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo
Tacrolimus ointment - Vitiligo
Phase 3CompletedOslo University Hospital2005-11-012008-12-12

Narrower conditions

Facies (1)  ·  Piebaldism (1)

Broader conditions

Hypopigmentation (12)  ·  Pigmentation Disorders (12)  ·  Skin Diseases (12)  ·  Skin and Connective Tissue Diseases (12)  ·  Albinism (1)  ·  Amino Acid Metabolism, Inborn Errors (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Cell Transplantation (1)  ·  Cell- and Tissue-Based Therapy (1)  ·  Fluorouracil (1)  ·  Lasers, Excimer (1)  ·  Latanoprost (1)  ·  Ophthalmic Solutions (1)  ·  Tacrolimus (1)  ·  Transplantation (1)  ·  ruxolitinib (1)

Sponsors

Centre Hospitalier Universitaire de Nice (3)  ·  Incyte Corporation (3)  ·  Henry Ford Health System (1)  ·  Laboratoires Genévrier (1)  ·  Oslo University Hospital (1)  ·  Royan Institute (1)  ·  South Valley University (1)  ·  University Hospital, Bordeaux (1)

Countries

France (8)  ·  United States (4)  ·  Bulgaria (3)  ·  Canada (3)  ·  Germany (3)  ·  Italy (3)  ·  Poland (3)  ·  Spain (3)  ·  Netherlands (2)  ·  Belgium (1)  ·  Egypt (1)  ·  Iran (1)

Top investigators

Kathleen Butler, MD (3)  ·  Eli Johanne Nordal, MD (1)  ·  Hassan M Ibrahim, professor (1)  ·  Hossein Baharvand, PhD (1)  ·  Iltefat H Hamzavi, MD (1)  ·  Nanja Van Geel, Pr (1)  ·  Nasser Aghdami, MD., PhD (1)  ·  Saeeid Shafieian, MD (1)

Results publications

PMID 41125994, PMID 36260792, PMID 40156697, PMID 20364383, PMID 33549606, PMID 39078582

NIH funding

2019 (2)